"The voice for cancer physicians and their patients in Massachusetts."
Food and Drug Administration (FDA) approved atezolizumab (Tecentriq, Genentech, Inc.) for adult and pediatric patients 2 years of age and older with unresectable or metastatic alveolar soft part sarcoma (ASPS). Read more.
Massachusetts Society of Clinical Oncologists ©2023
860 Winter Street, Waltham, MA, 02451
Tel: 781.434.7329 | email: firstname.lastname@example.org